Prospective Evaluation of Two iStent® Trabecular Stents, One iStent Supra® Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes

201880 citationsJournal Articlehybrid Open Access

Authors

Glaukos Corporation.

Good health and well-being

Published in: Advances in Therapy

Volume 35, Issue 3, pp. 395-407

Field-Weighted Citation Impact: 9.31